Skip to content

Cortical Resections in Drug Resistant Epilepsy

Evaluation of Safety and Efficacy of Cortical Resections for Seizure Control for Patients With Drug Resistant Epilepsy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04553354
Enrollment
35
Registered
2020-09-17
Start date
2020-09-10
Completion date
2022-11-10
Last updated
2020-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Resistant Epilepsy, Epilepsy Surgery

Brief summary

The aim of the study is to evaluate safety and efficacy of epilepsy surgery in the form of cortical resections in patients with refractory epilepsy and to review outcomes of resection procedures in focal epilepsy.

Detailed description

Nearly one-third of epilepsy patients are refractory/resistant to medical treatment . Refractory or drug-resistant epilepsy is defined as resistance to treatment with two appropriately chosen and tolerated antiepileptic drugs (AED) . Nevertheless, epilepsy surgery is an effective alternative treatment for some patients as it suggests seizure freedom . During the past 3 decades, surgery has found more acceptance as an option for drug-resistant epilepsy . Developments made in surgical techniques (cortical resections) have significantly increased the effectiveness and safety of these techniques; as such techniques have been demonstrated to improve seizure control/freedom outcomes and enhanced quality of life in patients . Neuro imaging developments with the introduction of positron emission tomography (PET), magnetic resonance imaging (MRI), functional MRI, single-photon emission computed tomography (SPECT), and magneto encephalography, electroencephalography and neuronavigation have facilitated the presurgical evaluation of patients, thus providing the lesion-directed surgeries more possible , also reducing the number and severity of complications . Complications of epilepsy surgery including failure to stop seizures and neuropsychological, psychosocial, or psychiatric impairment are still difficult to define, and there is no universal consensus in this regard . This technique characterized by : • Once the epilepsy focus is located by using interpretation and collection of data from functional MRI, EEG long term video and clinical findings, the specific surgery involved in treatment is decided on. The type of surgery depends on the location of the seizure focal point. Surgeries for epilepsy treatment include, but are not limited to, the following types: temporal lobe resection, ground temporal and extra temporal resection, parietal resection, occipital resection, frontal resection, extra temporal resection.

Interventions

PROCEDUREcortical resections

is the removal of the epileptic focus either temporal or extra temporal area

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients with focal epilepsy who are refractory to medical treatment. * Patients accept surgical maneuver

Exclusion criteria

* Epileptic patients responding to medical treatment. * Patients refusing surgical intervention. * Patients unfit for brain surgery. * Multi focal or generalized seizures.

Design outcomes

Primary

MeasureTime frameDescription
decrease incidence of drug adverse effects in drug resistant focal epilepsybaselinethe well known adverse effects of AEDs that are mentioned in literature as affection of the liver and kidney will be measured preoperatively by kidney function and liver function tests to detect if it is normal or not
control of focal epilepsy in drug resistant epileptic patientsbaselineseizure freedom after cortical resections will be measured by angel classification

Secondary

MeasureTime frameDescription
change quality of life of patients with drug resistant epilepsybaselinechanging quality of life of those patients as regards socioeconomic status of the patients if they get a jop or not and remain in his jop or not and the financial status improved or not and all of this will be mentioned by the patients in follow up in out patient clinic

Contacts

Primary Contactmahmoud mostafa ammar, assistant lecturer
dr.mahmoud.ammar90@gmail.com+201026998340
Backup ContactRadwan Noby Mahmoud, professor
hannahomar@yahoo.com+201224480595

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026